Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION, USP

Last updated on 2019-03-09 History
Report ID 10718
Drug Identification Number 02387468
Brand name LABETALOL HYDROCHLORIDE INJECTION, USP
Common or Proper name LABETALOL HYDROCHLORIDE INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) LABETALOL HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20ML 1VL
ATC code C07AG
ATC description BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-05-01
Actual start date 2018-05-05
Estimated end date Unknown
Actual end date 2019-03-08
Shortage status Resolved
Updated date 2019-03-09
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v34 2019-03-09 English Compare
v33 2019-03-08 French Compare
v32 2019-03-08 English Compare
v31 2018-05-14 French Compare
v30 2018-05-14 English Compare
v29 2018-05-06 English Compare
v28 2018-05-04 French Compare
v27 2018-05-04 English Compare
v26 2018-05-04 English Compare
v25 2018-05-03 French Compare
v24 2018-05-03 English Compare
v23 2018-05-01 French Compare
v22 2018-05-01 English Compare
v21 2018-02-02 French Compare
v20 2018-02-02 English Compare
v19 2017-12-04 French Compare
v18 2017-12-04 English Compare
v17 2017-08-15 French Compare
v16 2017-08-15 English Compare
v15 2017-08-01 French Compare

Showing 1 to 20 of 34